Mycoplasma contamination is nearly invisible. Unlike bacterial or fungal contamination, which produces obvious cloudiness in culture media or visible colonies, mycoplasma grows to high concentrations without causing turbidity, color changes, or morphological changes you can spot under a standard light microscope. This is precisely what makes it so dangerous in cell culture: contamination rates in mammalian cell lines have been estimated between 11% and 30% across major repositories, largely because the organisms evade routine visual checks.
Why You Can’t See It Under a Microscope
Mycoplasma cells measure between 0.15 and 0.8 micrometers, which is at or below the diffraction limit of visible light (roughly 200 to 300 nanometers with standard optics). For comparison, a typical bacterium like E. coli is 1 to 2 micrometers long and easy to spot. Mycoplasma is so small it passes through 0.2-micrometer filters that are designed to sterilize solutions, and it remains completely undetectable when you check your flasks on an inverted microscope.
This is the core problem. Standard bacterial or fungal contamination in antibiotic-free culture is usually obvious within days: the media turns cloudy, the pH shifts, and you can see organisms floating or clumped under low magnification. Mycoplasma does none of this. Your media can look perfectly clear, your cells can appear normal, and contamination can persist for weeks or months without any visible warning sign.
What Happens to Contaminated Cells
In many cases, contaminated cells show no morphological changes at all. Researchers using FTIR microspectroscopy to study mycoplasma-infected brain tumor cells found no clear difference in cell shape or obvious bacterial presence between infected and non-infected cultures, even at high contamination levels. The cells simply looked normal under visible microscopy.
When effects do appear, they tend to be subtle and easy to attribute to other causes. Growth rate may slow slightly, particularly at high contamination levels. Some cultures show reduced viability over time or inconsistent experimental results. But these changes are gradual and nonspecific. You would not look at a contaminated flask and think “contamination” the way you would with a bacterial bloom or fungal hyphae.
At the ultrastructural level, electron microscopy reveals what light microscopy cannot. Scanning electron microscopy studies show mycoplasma cells attaching tightly to host cell membranes, sometimes fusing at the tip of filamentous extensions. The attachment can be tight enough to indent the host cell surface and distort its shape. But this level of detail requires specialized equipment far beyond routine lab monitoring.
What Fluorescence Staining Reveals
The most accessible visual detection method uses DNA-binding fluorescent dyes like DAPI or Hoechst 33258. In a clean culture, these dyes light up only the cell nuclei, producing bright, well-defined spots against a dark background. In a contaminated culture, you see faint fluorescent speckling outside the nuclei, scattered across the cell surface and in the spaces between cells. This extranuclear fluorescence represents mycoplasma DNA.
The challenge is that mycoplasma DNA produces a very weak signal compared to the bright nuclear staining. Under standard acquisition settings, the nuclear signal can be so intense that it saturates the image and makes it impossible to resolve mycoplasma in or near the nuclear area. Increasing the exposure time brightens the mycoplasma signal but also saturates the nuclei further. Researchers have found that keeping nuclear saturation below 5% of the nuclear area gives the best chance of distinguishing contamination, but even then, the mycoplasma signal remains faint and can be ambiguous. Newer methods using enzymatic signal amplification rather than direct dye staining improve sensitivity, but the basic DAPI/Hoechst approach remains the quickest screening tool available.
Colony Appearance on Agar
When mycoplasma is cultured on specialized agar media, it produces colonies with a characteristic “fried egg” appearance: a dense, granular center embedded in the agar surrounded by a flatter, more translucent outer zone. These colonies are tiny, typically requiring a dissecting microscope or at least low-power magnification to identify. They look nothing like the large, opaque bacterial colonies you might be used to seeing on a standard agar plate.
Growing mycoplasma on agar is part of the gold standard detection method, but it requires specialized media, careful technique, and up to 28 days of incubation. Many mycoplasma species are slow growers or fail to grow on agar entirely, which limits the usefulness of this approach as a standalone detection method.
How Contamination Is Actually Detected
Because mycoplasma is essentially invisible to routine observation, labs rely on dedicated testing methods rather than visual inspection. The three main approaches are culture-based assays, fluorescent staining, and PCR.
- Culture method: The traditional gold standard combines broth culture, agar plating, and fluorescent antibody detection of non-cultivable organisms. It takes 28 days to complete, which makes it impractical for time-sensitive applications like cellular therapies with short shelf lives.
- Fluorescent staining: Fast and inexpensive, but limited by the weak signal mycoplasma DNA produces relative to nuclear DNA. Best used as a routine screening tool rather than a definitive test.
- PCR-based assays: Molecular testing can deliver results in hours and detect contamination at concentrations as low as 10 colony-forming units per milliliter. European and Japanese pharmacopeia standards accept PCR methods when they meet this sensitivity threshold. For labs manufacturing cell-based therapies, PCR has become the practical alternative to the 28-day culture test.
Regulatory bodies require that cell-based therapies be proven free of mycoplasma before release. The FDA and international pharmacopeias all mandate testing, reflecting how common and how consequential undetected contamination can be.
How Widespread the Problem Is
Mycoplasma contamination is not a rare event. The FDA tested over 20,000 cell cultures by the early 1990s and found 15% contaminated. A German study of 440 cell lines, mostly leukemia and lymphoma lines, found 28% contaminated. One Argentine study of 200 samples found a striking 70% contamination rate, though the sample size was small. A large-scale analysis of RNA sequencing data in the NCBI’s public archive estimated that about 11% of datasets from cultured samples contained mycoplasma, while none of the datasets from non-cultured samples showed contamination.
These numbers reflect the fundamental challenge: an organism that produces no visible signs of infection, resists standard antibiotics, slips through sterilization filters, and quietly alters the biology of every cell it touches. Routine testing on a set schedule, rather than waiting for something to look wrong, is the only reliable way to catch it.